anticancer property of bryophyllum pinnata (lam.) oken. leaf on human cervical cancer cells
Article Quality & Performance Metrics
Readership in this journal
SteadyRanked #4 of 12 articles by views in discrete optimization
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
Abstract
Background
Methods
A chloroform extract derived from a bulk of botanically well-characterized pulverized
Results
Results showed presence of growth inhibitory activity in the crude leaf extracts with IC50 at 552 μg/ml which resolved to fraction F4 (Petroleum Ether: Ethyl Acetate:: 50:50) and showed IC50 at 91 μg/ml. Investigations of anti-viral activity of the extract and its fraction revealed a specific anti-HPV activity on cervical cancer cells as evidenced by downregulation of constitutively active AP1 specific DNA binding activity and suppression of oncogenic c-Fos and c-Jun expression which was accompanied by inhibition of HPV18 transcription. In addition to inhibiting growth, fraction F4 strongly induced apoptosis as evidenced by an increased expression of the pro-apoptotic protein Bax, suppression of the anti-apoptotic molecules Bcl-2, and activation of caspase-3 and cleavage of PARP-1. Phytochemical analysis of fraction F4 by HPTLC and NMR indicated presence of activity that resembled Bryophyllin A.
Conclusions
Our study therefore demonstrates presence of anticancer and anti-HPV an activity in
| Reference Key |
sutapa2012bmcanticancer
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Mahata Sutapa;Maru Saurabh;Shukla Shirish;Pandey Arvind;Mugesh G;Das Bhudev C;Bharti Alok C |
| Journal | discrete optimization |
| Year | 2012 |
| DOI |
10.1186/1472-6882-12-15
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.